Biomaterials and Models in Regenerative Medicine
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: 31 March 2025
Special Issue Editors
Interests: stem cells; tissue engineering; regenerative medicine; adipose tissue; macrophages; in vitro cell models; in vivo animal models; wound healing; chronic wounds; biomaterials; molecular and human genetics
Special Issues, Collections and Topics in MDPI journals
Interests: regeneration of skeletal tissues assisted by biomaterials and stem cells; tissue engineering models; macrophages; examination of biological activity of the various substances in animal models in vivo and cell models in vitro
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce the new Special Issue for Pharmaceutics entitled "Biomaterials and Models in Regenerative Medicine".
Various biomaterials are constantly used in tissue engineering and regenerative medicine, and there is still a great need for improvement in this area. Biomaterials used in regenerative medicine should be biocompatible and should enable cell adhesion, migration, proliferation, differentiation, and regeneration. Biomaterials should mimic the natural structure of the extracellular matrix and represent a physiological microenvironment for cellular functions. They should induce tissue regeneration and have adequate biodegradability properties, as well as the ability to deliver bioactive substances if they are used as carriers and delivery systems. Prior to potential clinical applications, biomaterials have to be thoroughly tested in preclinical studies using various in vitro cell models and in vivo animal models.
This Special Issue on "Biomaterials and Models in Regenerative Medicine" encourages authors to submit their original research or review articles that bring newly developed biomaterials, methods, solutions, delivery systems, tissue engineering solutions, and models for regenerative medicine and pharmaceutical purposes. Topics include, but are not limited to, the following: biomaterial design and testing, smart biomaterials, biocompatibility testing in vitro, biocompatibility testing in vivo, regenerative potential testing, stem cells, 2D and 3D cell cultures, in vitro cell models for soft and hard tissue regeneration, in vitro cell models for testing drugs and medical devices for regenerative medicine applications, personalized in vitro cell models, matrices and scaffolds for 3D cell models, biomaterials as delivery systems, 3D printing, bioreactors, wound healing, and pharmaceutics in regenerative medicine. Additionally, the application of machine learning methods in biomaterial design and testing is welcomed.
Dr. Sanja Stojanović
Prof. Dr. Stevo Najman
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- scaffolds
- soft and hard tissue regeneration
- in vitro cell models
- in vivo animal models
- biocompatibility in vitro
- biocompatibility in vivo
- 3D printing
- stem cells
- bioreactors
- organ-on-chip
- delivery systems
- wound healing
- machine learning in regenerative medicine
